AUGS/IUGA Scientific Meeting 2019-Short Oral Session 10

Video Transcription

Video Summary

In the video, the speaker discusses the use of vaginal estrogen therapy in postmenopausal women with a history of breast cancer. They highlight the high prevalence of urogenital symptoms, such as urinary tract infections and vulvovaginal atrophy, in these women and the potential benefits of vaginal estrogen therapy in treating these symptoms. The speaker also addresses concerns about the use of estrogen in breast cancer survivors and presents evidence from observational studies suggesting that local estrogen therapy is safe and not associated with an increased risk of breast cancer recurrence. They discuss the importance of considering individual patient characteristics and discussing the potential benefits and risks of vaginal estrogen therapy with the patient's treating oncologist. The speaker also mentions alternative treatment options for urogenital symptoms, including non-pharmacological approaches such as moisturizers and lubricants, as well as energy-based therapies like laser therapy. Overall, the speaker provides guidance and considerations for clinicians when discussing the use of vaginal estrogen therapy with postmenopausal women with a history of breast cancer.

Asset Caption

Baylie Hochstedler, BS, Alan Wolfe, PhD, Carrie E Jung, MD, Lindsey Ann Jackson, MD, Rui Liang, MD, MSc, Danielle O'Shaughnessy, MD, Francesca Boscolo Sesillo, PhD, Mark Kibschull, PhD, David D. Rahn, MD

Keywords

vaginal estrogen therapy

postmenopausal women

breast cancer

urogenital symptoms

observational studies

treating oncologist

alternative treatment options

moisturizers

laser therapy